{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:27:57Z","timestamp":1786724877064,"version":"build-2736575974"},"reference-count":20,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Black patients with endometrial cancer have nearly twice the mortality of White patients with endometrial cancer, but it is unclear if the disparity differs by age, independent of insurance status.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To compare, in a large cohort of insured patients, the disparity between Black and White individuals in survival for patients aged younger than 65 years vs those age 65 years or older and to assess the association of age with excess mortality among Black patients.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This retrospective cohort study looked at comparative data from a community-based integrated health care system for Black and White patients diagnosed with endometrial cancer from January 1, 2005, to December 31, 2022. Data were analyzed between June 2025 and January 2026.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n Black and White race.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The disparity in 5-year mortality between Black and White patients was first assessed among patients younger than 65 years and those 65 years and older. The degree to which the gap in mortality in each age strata was accounted for by demographic, comorbid, tumor, treatment, and socioeconomic characteristics was further assessed using Cox proportional hazards models adjusted for these factors. To test whether age modifies the association between Black race and excess mortality, interaction terms between race and age were examined.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n From a sample of 13\u202f585 patients, 11\u202f530 White individuals and 2055 Black individuals, 6543 (48.2%) were younger than 65 years of age at diagnosis and 7042 (51.8%) were aged at least 65 years. The unadjusted hazard ratio (HR) for death among Black patients compared with White patients was 2.59 (95% CI, 2.21-3.03) for patients younger than 65 and 1.56 (95% CI, 1.40-1.73) for those aged at least 65 years at diagnosis. Comorbidities, tumor characteristics, treatment, and socioeconomic status accounted for the disparity among older patients (adjusted HR, 1.10; 95% CI, 0.97-1.24), but among younger patients some of the disparity remained unexplained (adjusted HR, 1.24; 95% CI, 1.04-1.49). Factors more associated with mortality among younger vs older Black patients were high-grade nonendometrioid disease (aHR, 6.09; 95% CI, 4.75-7.81 vs aHR, 3.42; 95% CI, 2.94-3.97) and distant disease (aHR, 8.38; 95% CI, 6.56-10.71 vs aHR, 4.97; 95% CI, 4.31-5.72). The adjusted hazard for mortality for Black women compared with White women was larger among patients younger than 65 years compared with older patients (multiplicative scale: aHR, 1.43; 95% CI, 1.18-1.75).<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cohort study of 13\u202f585 insured Black and White patients, the racial disparity in endometrial cancer survival was 43% larger among younger patients, associated with greater racial imbalances in the risk of adverse tumor types and distant disease, although some of the disparity remains unexplained.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.29596","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:30:22Z","timestamp":1786721422000},"page":"e2629596","source":"Crossref","is-referenced-by-count":0,"title":["Age and Endometrial Cancer Survival Disparities Among Black and White Insured Patients"],"prefix":"10.1001","volume":"9","author":[{"given":"Elizabeth J.","family":"Suh-Burgmann","sequence":"first","affiliation":[{"name":"Division of Gynecologic Oncology, The Permanente Medical Group, Pleasanton, California"},{"name":"Division of Research, Kaiser Permanente Northern California, Pleasanton"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Finertie","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Pleasanton"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyuan","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Nau","sequence":"additional","affiliation":[{"name":"Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Schmittdiel","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Pleasanton"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"issue":"4","key":"zoi260814r1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.4708","article-title":"Estimated projection of US cancer incidence and death to 2040.","volume":"4","author":"Rahib","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"6","key":"zoi260814r2","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1001\/jamaoncol.2022.0009","article-title":"Racial and ethnic differences in hysterectomy-corrected uterine corpus cancer mortality by stage and histologic subtype.","volume":"8","author":"Clarke","year":"2022","journal-title":"JAMA Oncol"},{"issue":"4","key":"zoi260814r3","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/AOG.0000000000004710","article-title":"Health disparities in uterine cancer: report from the uterine cancer evidence review conference.","volume":"139","author":"Whetstone","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"3","key":"zoi260814r4","doi-asserted-by":"publisher","first-page":"396.e1","DOI":"10.1016\/j.ajog.2020.02.021","article-title":"Impact of quality of care on racial disparities in survival for endometrial cancer.","volume":"223","author":"Huang","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"zoi260814r5","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1001\/jamaoncol.2024.1891","article-title":"Endometrial thickness as diagnostic triage for endometrial cancer among black individuals.","volume":"10","author":"Doll","year":"2024","journal-title":"JAMA Oncol"},{"issue":"1","key":"zoi260814r6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ygyno.2017.07.145","article-title":"Impact of age at diagnosis on racial disparities in endometrial cancer patients.","volume":"149","author":"Tarney","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"4","key":"zoi260814r7","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.8437","article-title":"Factors associated with survival disparities between non-Hispanic Black and white patients with uterine cancer.","volume":"6","author":"Kucera","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"8","key":"zoi260814r8","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.annepidem.2007.03.011","article-title":"A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients.","volume":"17","author":"Klabunde","year":"2007","journal-title":"Ann Epidemiol"},{"issue":"6","key":"zoi260814r10","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s11524-006-9094-x","article-title":"The development of a standardized neighborhood deprivation index.","volume":"83","author":"Messer","year":"2006","journal-title":"J Urban Health"},{"issue":"2","key":"zoi260814r12","first-page":"678","article-title":"Incidence trends in triple-negative breast cancer among women in the United States from 2010 to 2019 by race\/ethnicity, age and tumor stage.","volume":"13","author":"Du","year":"2023","journal-title":"Am J Cancer Res"},{"key":"zoi260814r13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.56142","article-title":"Incidence rate trends of breast cancer overall and by molecular subtype by race and ethnicity and age.","volume":"8","author":"Li","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"7","key":"zoi260814r14","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1001\/jamaoncol.2021.1492","article-title":"Comparison of the prevalence of pathogenic variants in cancer susceptibility genes in Black Women and Non-Hispanic White women with breast cancer in the United States.","volume":"7","author":"Domchek","year":"2021","journal-title":"JAMA Oncol"},{"issue":"4","key":"zoi260814r15","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/cncr.35071","article-title":"Pathogenic germline variants in patients with endometrial cancer of diverse ancestry.","volume":"130","author":"Liu","year":"2024","journal-title":"Cancer"},{"issue":"10","key":"zoi260814r16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.35821","article-title":"Epigenetic profiles of triple-negative breast cancers of African American and White females.","volume":"6","author":"Ensenyat-Mendez","year":"2023","journal-title":"JAMA Netw Open"},{"key":"zoi260814r17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ygyno.2025.04.584","article-title":"Association of endometrial cancer epigenetic mismatch repair deficiency with clinicopathologic factors and survival in a large, diverse community-based cohort.","volume":"197","author":"Suh-Burgmann","year":"2025","journal-title":"Gynecol Oncol"},{"issue":"10","key":"zoi260814r18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.37378","article-title":"Social adversity and triple-negative breast cancer incidence among US Black women.","volume":"8","author":"Hernandez","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"9","key":"zoi260814r19","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s10552-019-01202-1","article-title":"Systematic review on socioeconomic deprivation and survival in endometrial cancer.","volume":"30","author":"Donkers","year":"2019","journal-title":"Cancer Causes Control"},{"key":"zoi260814r20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.annepidem.2019.02.011","article-title":"The weathering hypothesis as an explanation for racial disparities in health: a systematic review.","volume":"33","author":"Forde","year":"2019","journal-title":"Ann Epidemiol"},{"key":"zoi260814r9","volume-title":"Summary Stage 2018: Codes and Coding Instructions","author":"Ruhl","year":"2021"},{"key":"zoi260814r11","unstructured":"Babatunde? AY. InteractionR: An R package for full reporting of effect modification and interaction. 2021. Accessed July 1, 2026. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2665963821000610"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2852813\/suhburgmann_2026_oi_260814_1786550602.31822.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:30:24Z","timestamp":1786721424000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2852813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.29596","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]}}}